PRESS RELEASE FOR NATURE NEUROSCIENCE
(<http://www.nature.com/neuro>)
This press release is copyrighted to Nature Neuroscience.
A PDF of the paper mentioned on this release can be found in the relevant journal’s section of http://press.nature.com. Press contacts for the Nature journals are listed at the end of this release.
Warning: This document, and the Nature paper to which it refers, may contain information that is price sensitive (as legally defined, for example, in the UK Criminal Justice Act 1993 Part V) with respect to publicly quoted companies. Anyone dealing in securities using information contained in this document or in advanced copies of Nature’s content may be guilty of insider trading under the US Securities Exchange Act of 1934.
PLEASE CITE Nature NEUROSCIENCE AND THE Nature NEUROSCIENCE WEBSITE AS THE SOURCE OF THE FOLLOWING ITEM. IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO www.nature.com/neuro <http://www.nature.com/neuro>
Focus on childhood developmental disorders
A special focus issue on childhood developmental disorders, including specific language impairment and dyslexia, autism, and the mental retardation syndrome fragile X, is presented in the October issue of Nature Neuroscience. Four articles explore current knowledge about these disorders and suggest avenues for future research.
Childhood developmental disorders have a pervasive influence on the children affected, their families, and society in general. Because many of the symptoms manifest themselves in educational settings, schools also need to take into account the needs of these children. Studying childhood developmental disorders sheds light on what is ‘normal’ as well: autism may consist of a constellation of traits found in less extreme form in the general population, and language disorders are likely to provide clues about the evolution of language. There are also commonalities between different disorders traditionally considered separately; understanding these commonalities can shed light on the genetic and neural networks involved. Such information can help us to understand the pathways linking genes to specific neural circuits and to behavior in disorders like dyslexia. Researchers hope this will ultimately lead to treatments that go beyond symptom management.
[1] From genes to behavior in developmental dyslexia
DOI: 10.1038/nn1772
[2] Time to give up on a single explanation for autism
DOI: 10.1038/nn1770
[3] Fragile X syndrome and autism at the intersection of genetic and neural networks
DOI: 10.1038/nn1765
[4] What developmental disorders can tell us about the nature and origins of language
DOI: 10.1038/nn1766
Author contacts:
Albert Galaburda (Beth Israel Deaconess Medical Center, Boston, MA, USA) Paper [1]
E-mail: [email protected]
Angelica Ronald (Institute of Psychiatry, London, UK) Paper [2]
E-mail: [email protected]
Matthew Belmonte (Cornell University, Ithaca, NY, USA) Paper [3]
E-mail: [email protected] <mailto:[email protected]>
Gary Marcus (New York University, New York, NY, USA) Paper [4]
E-mail: [email protected]
PRESS CONTACTS…
Ruth Francis, Nature London
Tel: +44 20 7843 4562; E-mail [email protected]
Helen Jamison, Nature London
Tel: +44 20 7843 4658; E-mail: [email protected]
For media inquiries relating to editorial content/policy for Nature Biotechnology, please contact the journal directly:
Charvy Narain, Nature Neuroscience
Tel: +44 20 7014 4043; E-mail: [email protected]
About Nature Publishing Group
Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd, dedicated to serving the academic, professional scientific and medical communities. NPG's flagship title, Nature, is the world's most highly-cited weekly multidisciplinary journal and was first published in 1869. Other publications and services include Nature research journals, Nature Reviews, Nature Clinical Practice, a range of prestigious academic journals, including society-owned publications, news content from [email protected] and scientific career information from Naturejobs.
NPG is a global company, with headquarters in London and offices in New York, San Francisco, Washington DC, Boston, Tokyo, Paris, Munich, Hong Kong, Melbourne, Gurgaon, Mexico City and Basingstoke. For more information, please go to www.nature.com.
